col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


81 Results       Page 1

 [1] 
The Journal of Rheumatology: The Journal of Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2023―May―01 Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2 Kelly Corbitt, Peter Izmirly, Amit Saxena
2 [GO] 2023―Mar―15 Biologic sex inequality in rheumatology wait times during the COVID-19 pandemic Steven J. Katz, Carrie Ye
3 [GO] 2023―Mar―15 COVID-19 Vaccination as a Trigger of IgA Vasculitis: Truth or Illusion? Gang Wang, Ying Luo, Bihui Li, Jie Li
4 [GO] 2023―Feb―01 Importance of SARS-CoV-2 Spike Antibodies and B Cell Reconstitution to Optimize the Prevention Strategy of COVID-19 Marion Thomas, Jérôme Avouac
5 [GO] 2023―Jan―15 Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsk, Ann E. Clarke, et al. (+9)
6 [GO] 2023―Jan―15 Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications Claire Cook, Naomi J. Patel, Xiaoqing Fu, Xiaosong Wang, Yumeko Kawano, Kathleen M.M. Vanni, et al. (+7)
7 [GO] 2022―Dec―15 COVID-19 and IgA Vasculitis Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
8 [GO] 2022―Dec―15 B-cell reconstitution is associated with COVID-19 booster vaccine responsiveness in previously seronegative rituximab treated patients Kaitlin Schultz, Deanna Jannat-Khah, Robert Spiera
9 [GO] 2022―Dec―15 COVID-19 Disrupts Rheumatology Care: An Opportunity for Innovation? Rebecca Grainger, Valerie Milne
10 [GO] 2022―Dec―15 Oral antiviral treatment for COVID-19 in patients with systemic autoimmune rheumatic diseases Nafsika Gerolymatou, Athanasios-Dimitrios Bakasis, Paraskevi V. Voulgari, Panayiotis G. Vlachoyiannopoulos
11 [GO] 2022―Dec―15 COVID-19 vaccination perceptions in rheumatology patients: a cross-sectional online survey Imama Noor Butt, Charmaine van Eeden, Katharina Kovacs Burns, Lynora Saxinger, Alison Clifford, Jan Willem Cohen Tervaert, Elaine Yacyshyn
12 [GO] 2022―Dec―01 Impact Factor Jumps After the 2020 COVID-19 Pandemic: A Retrospective Study in Rheumatology Journals Abril-Carolina Mendoza-Lopez, Leslie-Marisol Gonzalez-Hermosillo, Ernesto Roldan-Valadez
13 [GO] 2022―Nov―15 COVID-19 vaccination as a trigger of IgA vasculitis: a global pharmacovigilance study Yanis Ramdani, Bérenger Largeau, Annie-Pierre Jonville-Bera, François Maillot, Alexandra Audemard-Verger
14 [GO] 2022―Nov―15 Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: A multicenter retrospective cohort study Kanon Jatuworapruk, Panchalee Satpanich, Philip C. Robinson, Rebecca Grainger
15 [GO] 2022―Nov―01 IgA vasculitis following COVID-19 vaccination: A French multicentre case series including 12 patients Yanis Ramdani, Thomas Bettuzzi, Amel Bouznad, Léa Delaitre, Kladoum Nassarmadji, Kevin Didier, et al. (+10)
16 [GO] 2022―Oct―15 The Third Dose Is the Charm: Effective Cellular and Humoral Immune Responses to Third COVID-19 Vaccine Doses in Immunosuppressed Nonresponders Wilson Kuswanto, Matthew C. Baker
17 [GO] 2022―Oct―01 Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021 Anju Murayama, Sae Kamamoto, Kenichi Higuchi, Haruki Shigeta, Akihiko Ozaki
18 [GO] 2022―Oct―01 Changes in service delivery and access to rheumatologists pre- and during the COVID-19 pandemic in a Canadian universal healthcare setting Timothy S.H. Kwok, Bindee Kuriya, Lauren K King, Lihi Eder, Carter Thorne, Zhiyin Li, et al. (+4)
19 [GO] 2022―Oct―01 Livedo reticularis after COVID-19 vaccination Taro Horino, Satoshi Inotani, Kimiko Nakajima, Yoshio Terada
20 [GO] 2022―Oct―01 Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines Carolina A. Isnardi, Osvaldo L. Cerda, Margarita Landi, Leonel Cruces, Emilce E. Schneeberger, Claudia Calle Montoro, et al. (+24)
21 [GO] 2022―Sep―01 IgA vasculitis following COVID-19: a French multicentric case-series Yanis Ramdani, Jean-Marc Galempoix, Jean François Augusto, Eva Dekmeer, Laurent Perard, Nicole Ferreira, et al. (+8)
22 [GO] 2022―Sep―01 From Canadian Living Guidelines to Global Living Guidelines: A Post Pandemic Effort Ines Colmenga, Michael E. Weinblatt
23 [GO] 2022―Aug―15 Adult-Onset Still Disease After ChadOx1 nCOV-19 Vaccination Jian Weng, Linghong Linda Zhou, Thomas Hahn, Kamran Shojania, Jan Dutz
24 [GO] 2022―Aug―01 Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association? Anastasios Karamanakos, Gerasimos Evangelatos, Maria Pappa, Kalliopi Fragiadaki, Antonis Fanouriakis, George E. Fragoulis
25 [GO] 2022―Jul―01 COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN) Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong, et al. (+4)
26 [GO] 2022―Jun―15 Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines Takamasa Kitajima, Atsushi Funauchi, Toshiki Nakajima, Satoshi Marumo, Yoshitaka Imura, Motonari Fukui
27 [GO] 2022―Jun―15 Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic Jérôme Avouac, Anna Molto, Camélia Frantz, Sarah Wanono, Elise Descamps, Olivier Fogel, et al. (+4)
28 [GO] 2022―Jun―15 Long-term behavioral changes during the COVID-19 pandemic and impact of vaccination in patients with inflammatory rheumatic diseases Bente Glintborg, Dorte Vendelbo Jensen, Lene Terslev, Oliver Hendricks, Mikkel Østergaard, Simon Horskjær Rasmussen, et al. (+14)
29 [GO] 2022―Apr―15 Post SARS-CoV-2 Vaccine Chilblains-like Lesions Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
30 [GO] 2022―Mar―01 Time since rituximab treatment is essential for developing a humoral response to COVID-19 mRNA vaccines in patients with rheumatic diseases Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels, Jakob Bøgh Andersen, Signe Risbøl Vils, Clara Elbæk Mistegaard, et al. (+6)
31 [GO] 2022―Mar―01 COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination Philip J. Mease, Kevin Winthrop, Wendy Olsder, Jeffrey R. Curtis
32 [GO] 2022―Mar―01 Immunogenicity of COVID-19 vaccination in patients with ankylosing spondylitis: a monocentric prospective belgian cohort study Tracy Vandergraesen, Leila Mekkaoui, Hafid Dahma, Muhammad Soyfoo, Laure Tant
33 [GO] 2022―Feb―01 Telemedicine Use During the COVID-19 Pandemic by Resilient Rheumatology Providers: A National Veterans Affairs Follow-up Survey Jasvinder A. Singh, John S. Richards, Elizabeth Chang, Amy M. Joseph, Bernard Ng
34 [GO] 2022―Feb―01 Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients Camille Le Moine, Muhammad Shahnawaz Soyfoo, Leila Mekkaoui, Hafid Dahma, Laure Tant
35 [GO] 2022―Feb―01 COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls Lihi Eder, Ruth Croxford, Aaron M. Drucker, Arielle Mendel, Bindee Kuriya, Zahi Touma, et al. (+5)
36 [GO] 2022―Jan―15 COVID-19 Vaccination Uptake among individuals with Immune-Mediated Inflammatory Diseases in Ontario, Canada between December 2020 and October 2021: A population-based analysis Jessica Widdifield, Lihi Eder, Simon Chen, Jeffrey C. Kwong, Carol Hitchon, Diane Lacaille, et al. (+3)
37 [GO] 2022―Jan―15 Safety profile and low risk of disease relapse after BNT162b2 mRNA SARS-COV-2 vaccination in patients with rare rheumatic diseases Marco Fornaro, Vincenzo Venerito, Florenzo Iannone, Fabio Cacciapaglia
38 [GO] 2021―Dec―15 Vasculitis As Temporally Associated With COVID-19 Infection or Vaccination: A Single-center Experience Alojzija Hočevar, Zoran Simonović, Žiga Rotar, Matija Tomšič
39 [GO] 2021―Nov―15 Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study Jeffrey R. Curtis, Xiaofeng Zhou, David T. Rubin, Walter Reinisch, Jinoos Yazdany, Philip C. Robinson, et al. (+4)
40 [GO] 2021―Nov―01 COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP Cristina Calvo, Clara Udaondo
41 [GO] 2021―Oct―15 The Effect of COVID-19 Illness on Pregnant Patients With Rheumatic Disease: Early Reassuring Data Lisa R. Sammaritano
42 [GO] 2021―Oct―15 Impact of COVID-19 pandemic on appropriateness of diagnostic pathways of autoimmune diseases Teresa Carbone, Valentina Picerno, Vito Pafundi, Ernesto Esposito, Pietro Leccese, Angela Padula, Salvatore D'Angelo
43 [GO] 2021―Oct―15 Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases Tiphaine Goulenok, Chrystelle Francois, Céline Mendes, Fatima Farhi, Jean-Francois Alexandra, Diane Rouzaud, et al. (+2)
44 [GO] 2021―Oct―01 The Interplay between Covid-19 and Spondyloarthritis or Its Treatment James T. Rosenbaum, Michael H. Weisman, Hedley Hamilton, Cassie Shafer, Elin Aslanyan, Richard A. Howard, et al. (+4)
45 [GO] 2021―Oct―01 Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype? Agathe Sauret, Julien Stievenart, Perrine Smets, Louis Olagne, Benedicte Guelon, Olivier Aumaître, et al. (+2)
46 [GO] 2021―Sep―01 COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance Bonnie L. Bermas, Milena Gianfrancesco, Helen L. Tanner, Andrea M. Seet, Mathia C. Aguiar, Nasra K. Al Adhoubi, et al. (+32)
47 [GO] 2021―Aug―01 The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the World Sebastian E. Sattui, Philip C. Robinson
48 [GO] 2021―Jul―01 A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine? Alexa Simon Meara, Molly Silkoski,, Kai Quin, Wael Jarjour
49 [GO] 2021―Jun―15 Impact of COVID-19 pandemic on rheumatology practice in Latin America Daniel G. Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, Sergio Kowalski, Ana Sapag, Antonio Cachafeiro-Vilar, et al. (+16)
50 [GO] 2021―Jun―01 The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know Katie Bechman, Mrinalini Dey, Mark Yates, Marwan Bukhari, Kevin Winthrop, James B. Galloway
51 [GO] 2021―May―15 Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases Glen S. Hazlewood, Jordi Pardo, Cheryl Barnabe, Orit Schieir, Claire E.H. Barber, Sasha Bernatsky, et al. (+16)
52 [GO] 2021―Mar―15 Risk of severe coronavirus infection (COVID-19) in patients with inflammatory rheumatic diseases. Javier Bachiller-Corral, Alina Boteanu, Maria Jesus Garcia-Villanueva, Carlos de la Puente, Marcelino Revenga, M. Consuelo Diaz-Miguel, et al. (+10)
53 [GO] 2021―Mar―15 Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting Philip J. Mease, Leonard H. Calabrese, Kristina Callis Duffin, Rebecca H. Haberman, Rodrigo Firmino, Jose U. Scher, et al. (+3)
54 [GO] 2021―Mar―01 COVID-19 and Rheumatic Diseases: It Is Time to Better Understand This Association Claudia D.L. Marques
55 [GO] 2021―Feb―15 Re-thinking Physical Activity Promotion during COVID-19 Pandemic: Focus on a 24-hour Day Linda C. Li, Lynne M. Feehan, Alison M. Hoens
56 [GO] 2021―Feb―01 Covid-19 in Children with Rheumatic Diseases in the Spanish National Cohort EPICO-AEP Cristina Calvo, Clara Udaondo
57 [GO] 2020―Dec―01 Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic Martina Orlandi, Nicholas Landini, Cosimo Bruni, Stefano Colagrande, Marco Matucci-Cerinic, Musataka Kuwana
58 [GO] 2020―Nov―15 Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic Michael George, Shilpa Venkatachalam, Shubhasree Banerjee, Joshua F. Baker, Peter A. Merkel, Kelly Gavigan, et al. (+4)
59 [GO] 2020―Nov―01 Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City Adam S. Faye, Kate E. Lee, Monika Laszkowska, Judith Kim, John William Blackett, Anna S. McKenney, et al. (+8)
60 [GO] 2020―Oct―15 The Effect of HLA-B27 on Susceptibility and Severity of COVID-19 James T. Rosenbaum, Hedley Hamilton, Michael H. Weisman, John D. Reveille, Kevin L. Winthrop, Dongseok Choi
61 [GO] 2020―Oct―15 Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review Puja Mehta, Sebastian E. Sattui, Kornelis S.M. van der Geest, Elisabeth Brouwer, Richard Conway, Michael S. Putman, et al. (+2)
62 [GO] 2020―Sep―15 Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease Linh Troung, Lila Pourzand, Elizabeth R. Volkmann
63 [GO] 2020―Sep―15 Attitudes and Behaviours of Patients with Rheumatic Diseases during the early stages of the COVID-19 Outbreak. Margaret H.Y. Ma, Sen Hee Tay, Peter P.M. Cheung, Amelia Santosa, Yiong Huak Chan, James W.L. Yip, et al. (+2)
64 [GO] 2020―Aug―15 Walk at least 10 minutes a day for adults with knee OA: Recommendation for minimal activity during the COVID-19 pandemic Jason T. Jakiela, Esther J. Waugh, Daniel K. White
65 [GO] 2020―Jul―01 Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues Sho Mokuda, Tadahiro Tokunaga, Junya Masumoto, Eiji Sugiyama
66 [GO] 2020―Jun―08 Rheumatologists and Pulmonologists at Temple University weather the COVID-19 storm together Roberto Caricchio, Gerard J. Criner
67 [GO] 2020―Jun―08 Teamwork, A Novel Concept During an Infectious Pandemic? Randy Q. Cron, W. Winn Chatham
68 [GO] 2020―Jun―01 No SLE with COVID-19 in Hong Kong: the effect of masking? Ho So, Joyce Wing Yan Mak, Lai-shan Tam
69 [GO] 2020―Jun―01 Are patients with systemic lupus erythematosus at increased risk of severe COVID-19? Ennio Giulio Favalli, Elena Agape, Roberto Caporali
70 [GO] 2020―May―25 Evidence of protective effect of hydroxychloroquine to prevent COVID-19 Beuy Joob, Viroj Wiwanitkit
71 [GO] 2020―May―25 Treating Covid-19 at the Inflection Point W. Winn Chatham, Randy Q. Cron
72 [GO] 2020―May―25 SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to learn from Rheumatologists? Carlos Antonio Mouraa, Ana Luísa Cerqueira de Sant’Ana Costa
73 [GO] 2020―May―18 COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics? Hannah Jethwa, Ann Sullivan, Sonya Abraham
74 [GO] 2020―May―11 Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials Stephen J. Balevic, Christoph P. Hornik, Thomas P. Green, Megan E.B. Clowse, Daniel Gonzalez, Anil R. Maharaj, et al. (+5)
75 [GO] 2020―Apr―25 Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis Ennio Giulio Favalli, Elena Agape, Roberto Caporali
76 [GO] 2020―Apr―25 The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic Randy Q. Cron, W. Winn Chatham
77 [GO] 2020―Apr―25 Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs Giovanni Filocamo, Francesca Minoia, Simone Carbogno, Stefania Costi, Micol Romano, Rolando Cimaz
78 [GO] 2020―Apr―08 Learning from Adversity: Lessons from the COVID-19 Crisis Michael S. Putman, Eric M. Ruderman
79 [GO] 2020―Apr―08 Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic Christine A. Peschken
80 [GO] 2020―Apr―02 Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic Rosie Scuccimarri, Evelyn Sutton, Mary-Ann Fitzcharles
81 [GO] 2020―Mar―24 The Rheumatologist’s Role in Covid-19 Randy Q. Cron, W. Winn Chatham
 [1] 

81 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec